People living with schizophrenia often worry about losing their memory as they age. New reviews suggest they face a two- to threefold increased risk of dementia. This isn't because schizophrenia automatically turns into Alzheimer's. Instead, it reflects a mix of early brain development issues, aging, and other life factors. Many patients actually remain cognitively stable, but some groups show gradual or faster decline.
Genetic links between schizophrenia and Alzheimer's are modest, and connections with frontotemporal dementia are only partial. Standard tests like the MMSE or MoCA might overestimate how common dementia is in this group because these tools can be confused by baseline cognitive deficits. This means a low score doesn't always mean a patient has neurodegenerative disease.
Current evidence does not support a uniform progression toward Alzheimer-type neurodegeneration for everyone. Diagnostic biases and mixed patient experiences make the picture complex. To help patients, we need long-term studies using biomarkers and tailored diagnostic frameworks. These tools will help doctors distinguish between chronic cognitive impairment and true neurodegeneration, ensuring patients get the right support without unnecessary fear.